These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11577405)

  • 1. [3 cases of polymyalgia rheumatica (PMR), in which serum amyloid A was a useful index of the disease activity].
    Yamane T; Yamauchi H; Imaizumi Y; Senba T
    Ryumachi; 2001 Aug; 41(4):756-62. PubMed ID: 11577405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serum amyloid A as a useful index of disease activity in polymyalgia rheumatica].
    Yamane T; Yamauchi H; Abe N; Torio N; Shimada R; Senba T; Imaizumi Y; Nomura T
    Ryumachi; 2003 Jun; 43(3):544-8. PubMed ID: 12910963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A patient with polymyalgia rheumatica who exhibited fever as the main symptom for a long period].
    Abe N; Yamauchi H; Senba T; Torio N; Shimada R; Yamane T; Imaizumi Y
    Ryumachi; 2002 Oct; 42(5):815-9. PubMed ID: 12462022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenal gland hypofunction in active polymyalgia rheumatica. effect of glucocorticoid treatment on adrenal hormones and interleukin 6.
    Cutolo M; Straub RH; Foppiani L; Prete C; Pulsatelli L; Sulli A; Boiardi L; Macchioni P; Giusti M; Pizzorni C; Seriolo B; Salvarani C
    J Rheumatol; 2002 Apr; 29(4):748-56. PubMed ID: 11950017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of refractory polymyalgia rheumatica with infliximab: a pilot study.
    Salvarani C; Cantini F; Niccoli L; Catanoso MG; Macchioni P; Pulsatelli L; Padula A; Olivieri I; Boiardi L
    J Rheumatol; 2003 Apr; 30(4):760-3. PubMed ID: 12672196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of polymyalgia rheumatica with excessive increase of rheumatoid factor].
    Hoshina H
    Ryumachi; 1997 Oct; 37(5):696-701. PubMed ID: 9396372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum amyloid A concentrations in giant-cell arteritis and polymyalgia rheumatica: a useful test in the management of the disease.
    Hachulla E; Saile R; Parra HJ; Hatron PY; Gosset D; Fruchart JC; Devulder B
    Clin Exp Rheumatol; 1991; 9(2):157-63. PubMed ID: 1711943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute-phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica: a prospective followup study.
    Salvarani C; Cantini F; Niccoli L; Macchioni P; Consonni D; Bajocchi G; Vinceti M; Catanoso MG; Pulsatelli L; Meliconi R; Boiardi L
    Arthritis Rheum; 2005 Feb; 53(1):33-8. PubMed ID: 15696567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A disease activity score for polymyalgia rheumatica.
    Leeb BF; Bird HA
    Ann Rheum Dis; 2004 Oct; 63(10):1279-83. PubMed ID: 15361387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum amyloid A as a potent therapeutic marker in a refractory patient with polymyalgia rheumatica.
    Shimojima Y; Matsuda M; Gono T; Ishii W; Ikeda S
    Intern Med; 2005 Sep; 44(9):1009-12. PubMed ID: 16258224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy.
    Martinez-Taboada VM; Bartolome MJ; Fernandez-Gonzalez MD; Blanco R; Rodriguez-Valverde V; Lopez-Hoyos M
    Rheumatology (Oxford); 2003 Sep; 42(9):1055-61. PubMed ID: 12730520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica.
    Boiardi L; Casali B; Farnetti E; Pipitone N; Nicoli D; Cantini F; Macchioni P; Bajocchi G; Catanoso MG; Pulsatelli L; Consonni D; Salvarani C
    J Rheumatol; 2006 Apr; 33(4):703-8. PubMed ID: 16583473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of the relationship between polymyalgia rheumatica and matrix metalloproteinase-3 levels during the first medical examination and during treatment].
    Miyake K; Katsuyama T
    Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(1):48-54. PubMed ID: 24598068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothalamic-pituitary-adrenal axis impairment in the pathogenesis of rheumatoid arthritis and polymyalgia rheumatica.
    Cutolo M; Foppiani L; Minuto F
    J Endocrinol Invest; 2002; 25(10 Suppl):19-23. PubMed ID: 12508908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic difficulties in polymyalgia rheumatica cases with normal erythrocyte sedimentation rate and C-reactive protein values.
    Kara M; Alp G; Koç AM
    Medicine (Baltimore); 2023 Sep; 102(39):e35385. PubMed ID: 37773830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment with clarithromycin and/or tacrolimus for two patients with polymyalgia rheumatica.
    Ohe M; Shida H; Horita T; Oku K
    Drug Discov Ther; 2017; 11(4):223-225. PubMed ID: 28867756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low serum levels of DHEAS in untreated polymyalgia rheumatica/giant cell arteritis.
    Narváez J; Bernad B; Díaz Torné C; Momplet JV; Montpel JZ; Nolla JM; Valverde-García J
    J Rheumatol; 2006 Jul; 33(7):1293-8. PubMed ID: 16783861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of the disease activity scores for polymyalgia rheumatica for predicting glucocorticoid dose changes: a study of 243 scenarios.
    Binard A; De Bandt M; Berthelot JM; Saraux A;
    Arthritis Rheum; 2007 Apr; 57(3):481-6. PubMed ID: 17394219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoid effects on adrenal steroids and cytokine responsiveness in polymyalgia rheumatica and elderly onset rheumatoid arthritis.
    Sulli A; Montecucco CM; Caporali R; Cavagna L; Montagna P; Capellino S; Fazzuoli L; Seriolo B; Alessandro C; Secchi ME; Cutolo M
    Ann N Y Acad Sci; 2006 Jun; 1069():307-14. PubMed ID: 16855158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of glucocorticoid-free remission in patients with polymyalgia rheumatica treated with prednisolone.
    Hattori K; Hirano Y; Kojima T
    Int J Rheum Dis; 2020 Nov; 23(11):1581-1586. PubMed ID: 32996694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.